insights_auto
Why is ARX up 2,54%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,50 AUD
arrow_upward
+2,54%(+0,012) 1D
18 ნოე, 15:30:05 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 AUD
High
0,51 AUD
Low
0,49 AUD
Mkt. cap
174,68 მლნ.
Avg. vol.
260,07 ათ.
Volume
237,73 ათ.
P/E ratio
48,10
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
Open
0,50 AUD
High
0,51 AUD
Low
0,49 AUD
Mkt. cap
174,68 მლნ.
Avg. vol.
260,07 ათ.
Volume
237,73 ათ.
P/E ratio
48,10
52-wk high
0,78 AUD
52-wk low
0,46 AUD
EPS
0,01 AUD
Shares outstanding
345,90 მლნ.
No. of employees
261
News stories
From web sources and news partners
TradingView
·
5 საათის წინ
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
7 საათის წინ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
7 საათის წინ
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
3 საათის წინ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd